Drug Company Aid Programs

As a matter of policy most pharmaceutical companies prefer to have their Myeloma patients apply to non-profit copay foundations for the financial aid money used to help pay for their drugs.

However, as of October 18, 2017 there are no copay assistance plans open to new Myeloma applicants and apparently aid has been suspended to those currently enrolled in programs. Within the last month Patient Advocate Foundation, Healthwell Foundation, Leukemia & Lymphoma Society, and CancerCare have closed joining Good Days from the Chronic Disease Fund and the Patient Access Network Foundation which suspended their services earlier in the year.

For now patients are advised to contact the financial aid programs of the drug manufacturers directly.

Celgene’s (Thalomid, Revlimid, & Pamalyst) patient support web portal can be found at:
https://www.celgenepatientsupport.com/

Takeda Financial Aid
Ninlaro 1Point Program:  https://www.ninlaro.com/cost
Velcade Support: http://www.velcade.com/paying-for-treatment/

Amgen Kyprolis
Amgen Assist 360 Program: http://www.amgenassist360.com/patient/kyprolis-cost-nurse-ambassador-assistance/

Janssen Darzalex
Janssen CarePath Program: https://www.darzalexhcp.com/cost-support/janssen-carepath#affordability

More to come (I’m sure).

2016 Health & Human Services Poverty Guidelines & Dollar Figures for 250%, 400% and 500% above the Federal Poverty Guidelines

100% 250% 400% 500%
1 $11,880 $29,700 $47,520 $59,400
2 $16,020 $40,050 $64,080 $80,100
3 $20,160 $50,400 $80,640 $100,800
4 $24,300 $60,750 $97,200 $121,500
5 $28,440 $71,100 $113,760 $142,200
6 $32,580 $81,450 $130,320 $162,900
7 $36,730 $91,825 $146,920 $183,650
8 $40,890 $102,225 $163,560 $204,450

 

Advertisements